These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 17613039)

  • 1. Diagnosis of bladder cancer at 465 MHz.
    Gervino G; Autino E; Kolomoets E; Leucci G; Balma M
    Electromagn Biol Med; 2007; 26(2):119-34. PubMed ID: 17613039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder cancer detection in patients with gross haematuria: Computed tomography urography with enhancement-triggered scan versus flexible cystoscopy.
    Helenius M; Brekkan E; Dahlman P; Lönnemark M; Magnusson A
    Scand J Urol; 2015; 49(5):377-81. PubMed ID: 25793362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
    Raitanen MP; Leppilahti M; Tuhkanen K; Forssel T; Nylund P; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):261-5. PubMed ID: 11820414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Can the combination of bladder ultrasonography and urinary cytodiagnosis replace cystoscopy in the diagnosis and follow-up of tumors of the bladder?].
    Cariou G; Maaraoui N; Cortesse A
    Prog Urol; 1997 Feb; 7(1):51-5. PubMed ID: 9116739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.
    El-Assmy A; Abou-El-Ghar ME; Refaie HF; Mosbah A; El-Diasty T
    BJU Int; 2012 Dec; 110(11 Pt B):E622-7. PubMed ID: 22757606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The early detection and diagnosis of bladder cancer: a critical review of the options.
    Saad A; Hanbury DC; McNicholas TA; Boustead GB; Woodman AC
    Eur Urol; 2001 Jun; 39(6):619-33. PubMed ID: 11464050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematuria: portal venous phase multi detector row CT of the bladder--a prospective study.
    Park SB; Kim JK; Lee HJ; Choi HJ; Cho KS
    Radiology; 2007 Dec; 245(3):798-805. PubMed ID: 17951346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microscopic hematuria as a predictive factor for detecting bladder cancer at cystoscopy in women with irritative voiding symptoms.
    Wu JM; Williams KS; Hundley AF; Jannelli ML; Visco AG
    Am J Obstet Gynecol; 2006 May; 194(5):1423-6. PubMed ID: 16579943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A; Kumar R; Gupta NP
    Jpn J Clin Oncol; 2006 Mar; 36(3):172-5. PubMed ID: 16520358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
    Zippe C; Pandrangi L; Potts JM; Kursh E; Novick A; Agarwal A
    Anticancer Res; 1999; 19(4A):2621-3. PubMed ID: 10470205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
    Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
    J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer.
    Zippe C; Pandrangi L; Agarwal A
    J Urol; 1999 Jan; 161(1):62-5. PubMed ID: 10037369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography urography for diagnosing bladder cancer.
    Turney BW; Willatt JM; Nixon D; Crew JP; Cowan NC
    BJU Int; 2006 Aug; 98(2):345-8. PubMed ID: 16879676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer detection with CT urography.
    Francica G; Scarano F
    Radiology; 2009 Mar; 250(3):956; author reply 956-7. PubMed ID: 19244059
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of ultrasonography and urinary cytology in diagnosing recurrence of superficial urinary bladder cancer compared to cystoscopy.
    Roy MK; Islam MF; Kibria SA
    Bangladesh Med Res Counc Bull; 2001 Apr; 27(1):23-32. PubMed ID: 11692897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
    Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
    J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and monitoring for bladder cancer: refining the use of NMP22.
    Ponsky LE; Sharma S; Pandrangi L; Kedia S; Nelson D; Agarwal A; Zippe CD
    J Urol; 2001 Jul; 166(1):75-8. PubMed ID: 11435827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
    Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
    BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer.
    Parekattil SJ; Fisher HA; Kogan BA
    J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.
    Tubaro A; De Nunzio C; Trucchi A; Stoppacciaro A; Miano L
    Urology; 2008 Aug; 72(2):340-4. PubMed ID: 18336888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.